Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

LF Verdonck; A Notenboom; DD de Jong; MA MacKenzie; GEG Verhoef; MHH Kramer; GJ Ossenkoppele; Jeanette Doorduijn; Pieter Sonneveld; GW van Imhoff

doi:10.1182/blood-2006-07-035709

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

LF Verdonck, A Notenboom, DD de Jong, MA MacKenzie, GEG Verhoef, MHH Kramer, GJ Ossenkoppele, Jeanette Doorduijn, Pieter Sonneveld, GW van Imhoff

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

35 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2759-2766
Number of pages	8
Journal	Blood
Volume	109
Issue number	7
DOIs	https://doi.org/10.1182/blood-2006-07-035709
Publication status	Published - 2007

Research programs

EMC MM-02-41-03

Access to Document

10.1182/blood-2006-07-035709

http://hdl.handle.net/1765/35505

Cite this

Verdonck, LF., Notenboom, A., de Jong, DD., MacKenzie, MA., Verhoef, GEG., Kramer, MHH., Ossenkoppele, GJ., Doorduijn, J., Sonneveld, P., & van Imhoff, GW. (2007). Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). Blood, 109(7), 2759-2766. https://doi.org/10.1182/blood-2006-07-035709

@article{f2365508d7db4817b49aafc28e94670f,

title = "Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)",

author = "LF Verdonck and A Notenboom and {de Jong}, DD and MA MacKenzie and GEG Verhoef and MHH Kramer and GJ Ossenkoppele and Jeanette Doorduijn and Pieter Sonneveld and {van Imhoff}, GW",

year = "2007",

doi = "10.1182/blood-2006-07-035709",

language = "Undefined/Unknown",

volume = "109",

pages = "2759--2766",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

Verdonck, LF, Notenboom, A, de Jong, DD, MacKenzie, MA, Verhoef, GEG, Kramer, MHH, Ossenkoppele, GJ, Doorduijn, J , Sonneveld, P & van Imhoff, GW 2007, 'Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)', Blood, vol. 109, no. 7, pp. 2759-2766. https://doi.org/10.1182/blood-2006-07-035709

Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). / Verdonck, LF; Notenboom, A; de Jong, DD et al.
In: Blood, Vol. 109, No. 7, 2007, p. 2759-2766.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)

AU - Verdonck, LF

AU - Notenboom, A

AU - de Jong, DD

AU - MacKenzie, MA

AU - Verhoef, GEG

AU - Kramer, MHH

AU - Ossenkoppele, GJ

AU - Doorduijn, Jeanette

AU - Sonneveld, Pieter

AU - van Imhoff, GW

PY - 2007

Y1 - 2007

U2 - 10.1182/blood-2006-07-035709

DO - 10.1182/blood-2006-07-035709

M3 - Article

C2 - 17132720

SN - 0006-4971

VL - 109

SP - 2759

EP - 2766

JO - Blood

JF - Blood

IS - 7

ER -

Verdonck LF, Notenboom A, de Jong DD, MacKenzie MA, Verhoef GEG, Kramer MHH et al. Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). Blood. 2007;109(7):2759-2766. doi: 10.1182/blood-2006-07-035709